HilleVax Inc

NASDAQ:HLVX  
1.89
+0.02 (+1.07%)
7:50:38 PM EDT: $1.93 +0.04 (+2.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

HilleVax Inc Stock, NASDAQ:HLVX

321 Harrison Avenue, Suite 500, Boston, Massachusetts 02118
United States of America
Phone: +1.617.213.5054
Number of Employees: 90
http://www.hillevax.com

Description

HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.